We have reported previously that in certain types of cancer cells, tTG expression can be up-regulated through EGFR-dependent signaling, and so we investigated whether there was an apparent difference in EGFR expression status between MES and PN GSCs [2, 4]. The gene discussed is TGM2; the disease is cancer.